Lilly Immergluck, MD, MS

Professor
Morehouse School of Medicine

Disclosure(s): GSK: Clinical Trial- PI; Merck: Vaccine Trial Site- serve as PI; Moderna: Board Member; Novavax: Part of CoVID-19 Phase 3 Trial through US Covid Prevention Network

Poster(s):

• 568 - Using Machine Learning to Predict Place-Based Risks for Staphylococcus aureus Infections in Children
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 1947 - Evaluating the Relationship Between Obesity and the Humoral Immune Response to COVID-19 Vaccines
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET